Evidence map›Paper›PMID 31235692›Full record

ArticleNature communications2019

Role of network-mediated stochasticity in mammalian drug resistance.

Kevin S Farquhar, Daniel A Charlebois, Mariola Szenk, Joseph Cohen, Dmitry Nevozhay, Gábor Balázsi

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Contributions of transcriptional noise to leukaemia evolution: KAT2A as a case-study.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  14. Adaptive DNA amplification of synthetic gene circuit opens a way to overcome cancer chemoresistance.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Kevin S FarquharThe Louis and Beatrice Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794, USA.ORCID http://orcid.org/0000-0001-8475-4982
Daniel A CharleboisThe Louis and Beatrice Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794, USA.ORCID http://orcid.org/0000-0001-7426-1789
Mariola SzenkThe Louis and Beatrice Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794, USA.
Joseph CohenDepartment of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794, USA.
Dmitry NevozhaySchool of Biomedicine, Far Eastern Federal University, 8 Sukhanova Street, Vladivostok, 690950, Russia.
Gábor BalázsiThe Louis and Beatrice Laufer Center for Physical and Quantitative Biology, Stony Brook University, Stony Brook, NY, 11794, USA. gabor.balazsi@stonybrook.edu.
The University of Texas MD Anderson Cancer Center · USStony Brook University · USUniversity of Alberta · CA

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
Dynamics and evolution of synthetic and natural gene regulatory networksR35GM122561 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI BALAZSI, GABOR · 2017 to 2025
$4.2M
Connecting the selection of noisy gene expression deviants to genetic evolutionDP2OD006481 · OD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BALAZSI, GABOR · 2009 to 2009
$2.3M
Spatially-delineated System-level Analyses and Control of Cytoskeletal RegulationR01GM106027 · NIGMS · RICE UNIVERSITY · PI BALAZSI, GABOR, DIEHL, MICHAEL R · 2013 to 2016
$1.2M
Ministry of Education and Science of the Russian Federation (Minobrnauka) program #1326NCI NIH HHS P30 CA016672NIGMS NIH HHS R01 GM106027NIGMS NIH HHS R35 GM122561NIH HHS DP2 OD006481
6 · The paper itself

Abstract

A major challenge in biology is that genetically identical cells in the same environment can display gene expression stochasticity (noise), which contributes to bet-hedging, drug tolerance, and cell-fate switching. The magnitude and timescales of stochastic fluctuations can depend on the gene regulatory network. Currently, it is unclear how gene expression noise of specific networks impacts the evolution of drug resistance in mammalian cells. Answering this question requires adjusting network noise independently from mean expression. Here, we develop positive and negative feedback-based synthetic gene circuits to decouple noise from the mean for Puromycin resistance gene expression in Chinese Hamster Ovary cells. In low Puromycin concentrations, the high-noise, positive-feedback network delays long-term adaptation, whereas it facilitates adaptation under high Puromycin concentration. Accordingly, the low-noise, negative-feedback circuit can maintain resistance by acquiring mutations while the positive-feedback circuit remains mutation-free and regains drug sensitivity. These findings may have profound implications for chemotherapeutic inefficiency and cancer relapse.

Indexed as

Models, GeneticAnimalsAntimetabolites, AntineoplasticCHO CellsComputer SimulationCricetulusDose-Response Relationship, DrugDrug Resistance, NeoplasmFeedback, PhysiologicalGene Expression RegulationGene Regulatory NetworksNeoplasmsPuromycinStochastic ProcessesAntimetabolites, AntineoplasticPuromycin

Identifiers

PMID31235692
PMCPMC6591227
OpenAlexW2951527048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.